Sage Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
26.03.24
/
50%
€17.20
Target price
26.03.25
€26.71
Performance (%)
-54.16%
End price
27.03.25
€7.88
Summary
This prediction ended on 27.03.25 with a price of €7.88. The BUY prediction by JPMorgan_Chase___Co_ for Sage Therapeutics Inc. performed very badly with a performance of -54.16%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sage Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 1.917% | 1.088% | 17.187% |
| iShares Nasdaq 100 | 0.911% | 1.674% | 7.930% |
| iShares Nikkei 225® | 0.833% | -1.712% | 12.100% |
| iShares S&P 500 | 0.242% | 1.258% | 3.167% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target raised by analysts at JPMorgan Chase & Co. from $24.00 to $29.00. They now have an "overweight" rating on the stock.
Ratings data for SAGE provided by MarketBeat
In the thread Trading Sage Therapeutics Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.63
12.07.24
12.07.24
€16.50
12.07.25
12.07.25
-26.40%
13.07.25
13.07.25
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.99
20.06.24
20.06.24
€21.44
20.06.25
20.06.25
-20.83%
21.06.25
21.06.25
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.59
01.05.24
01.05.24
€26.21
01.05.25
01.05.25
-48.02%
02.05.25
02.05.25